• Lisa Carter-Harris, Tan Andy S L AS Department of Social and Behavioral Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Medical Oncology, Dana-Farber Cancer Institute, Bo, Ramzi G Salloum, and Kelly C Young-Wolff.
• Indiana University School of Nursing, Indianapolis, IN, USA. Electronic address: lcharris@iu.edu.
• Patient Educ Couns. 2016 Nov 1; 99 (11): 1772-1777.

ObjectiveIn 2013, the USPSTF issued a Grade B recommendation that long-term current and former smokers receive lung cancer screening. Shared decision-making is important for individuals considering screening, and patient-provider discussions an essential component of the process. We examined prevalence and predictors of lung cancer screening discussions pre- and post-USPSTF guidelines.MethodsData were obtained from two cycles of the Health Information National Trends Survey (2012; 2014). The analyzed sample comprised screening-eligible current and former smokers with no personal history of lung cancer (n=746 in 2012; n=795 in 2014). Descriptive and multiple logistic regression analyses were conducted; patient-reported discussion about lung cancer screening with provider was the outcome of interest.ResultsContrary to expectations, patient-provider discussions about lung cancer screening were more prevalent pre-guideline, but overall patient-provider discussions were low in both years (17% in 2012; 10% in 2014). Current smokers were more likely to have had a discussion than former smokers. Significant predictors of patient-provider discussions included family history of cancer and having healthcare coverage.ConclusionsThe prevalence of patient-provider discussions about lung cancer screening is suboptimal.Practice ImplicationsThere is a critical need for patient and provider education about shared decision-making and its importance in cancer screening decisions.Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

28 keywords...

hide…